首页> 外文会议>Society for Biomaterials annual meeting and exposition >Polymersomes: Towards Treatment of Neurodegenerative Disorders through Enzyme Replacement Therapy
【24h】

Polymersomes: Towards Treatment of Neurodegenerative Disorders through Enzyme Replacement Therapy

机译:Polymersomes:通过酶替代疗法治疗神经退行性疾病

获取原文

摘要

Incorporation of both mannitol and inulin was confirmed using Fourier transform- infrared spectroscopy, with absorbance increasing with increasing molecule concentration. The PSDs of polymersomes were not negatively affected by the incorporation of molecules, with no statistically larger diameters found over a period of 2.5 hours when compared to empty polymersomes. At 120 minutes, the incorporation of mannitol at both 2 wt%/v and 8 wt%/v lead to polymersome diameters statistically smaller than empty polymersomes at the same time point. Karl Fischer titration showed that increasing inulin concentration decreased the moisture content found after lyophilization, which is beneficial to encapsulation of enzymes, whose activities are vastly affected with crystallization. The introduction of these molecules led to reproducible effects with respect to size control, allowing for the best opportunity to cross the BBB.
机译:使用傅里叶变换红外光谱法确认了甘露醇和菊粉的掺入,其吸光度随分子浓度的增加而增加。聚合体的PSD不受分子掺入的负面影响,与空的聚合体相比,在2.5小时内没有发现统计学上较大的直径。在120分钟时,以2wt%/ v和8wt%/ v的量引入甘露醇导致在同一时间点上的聚合体直径统计上小于空的聚合体。 Karl Fischer滴定法表明,增加菊粉浓度会降低冻干后的水分含量,这有利于酶的封装,酶的活性受结晶的影响很大。这些分子的引入在尺寸控制方面产生了可再现的效果,从而提供了穿越血脑屏障的最佳机会。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号